Wayfinding Financial’s Tenet Healthcare THC Stock Holding History

Wayfinding Financial’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-215	Closed	-$28K	–	645
2025 Q1	$28K	Buy	+215	New	+$28.3K	0.01%	490

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wayfinding Financial's THC Position: Q2 2025 in Review

Wayfinding Financial sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 215 shares — an estimated $28K sold.

Wayfinding Financial first reported a position in THC in Q1 2025 and held it in 1 quarter. The position peaked at $28K in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

Wayfinding Financial reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
Wayfinding Financial sold 215 Tenet Healthcare shares in Q2 2025, an estimated $28K.
Wayfinding Financial first reported a position in Tenet Healthcare in Q1 2025 and held it in 1 quarter.
Wayfinding Financial's Tenet Healthcare position peaked at $28K in Q1 2025.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Wayfinding Financial's 13F filing for Q2 2025, filed 12 Aug 2025.